Accumulus Synergy

Responsible Innovation

Next Generation Data and Information Exchange

We are a global nonprofit organization developing a communication and collaboration platform for the life science-regulatory ecosystem that aims to enhance the current methods of information and data exchange, ultimately benefiting patients around the globe.

A Regulatory-Centric Solution

Accumulus Synergy is creating a regulatory lifecycle solution, offering innovative technologies that aim to change industry ways of working. Our solution will strive to enable tremendous progress in the regulatory science space, particularly where there is the highest unmet medical need or public health opportunity.

An Information Superhighway

Accumulus Synergy is building an information superhighway that will help to facilitate standardization. Data from source to decision maker will facilitate real-time and efficient insight generation and global convergence toward single process, dataset, and submission.

Relevant to the Ecosystem

Accumulus Synergy is striving to be a convening hub, inclusive but not limited to pharmaceutical, biotechnology, generic, and medical device manufacturers, health authorities, and third-party solution developers.

Learn More About What We Do

News, Events & Publications

Accumulus Synergy Cloud Platform Shows ‘The Art of The Possible’

Never before have humans been so readily connected. And while global connectivity is great for staying in touch with friends or family or working from home, it also allows for profound jumps in innovation resulting from data exchange, global collaboration, and much more.

Towards the “Dossier In The Cloud” to Democratize Global Access to Medicines

Conversation with Accumulus Synergy CEO Francisco Nogueira. In February 2024, the nonprofit industry association Accumulus Synergy announced the launch of its initial cloud-based information and data exchange platform through a regulatory reliance pilot project. 

Unleashing the Power of Reliance for Post-Approval Changes with 48 NRAs

Post-approval changes (PACs) are an essential part of product lifecycle management to ensure continuous supply of life-saving medicines in case of increased demand, to support continuous improvement and optimization of the manufacturing process, to remain state-of-the-art with analytical techniques, and to ensure continuity to comply with the updated regulatory requirements.